Detalhe da pesquisa
1.
Amyloid myopathy: expanding the clinical spectrum of transthyretin amyloidosis-case report and literature review.
J Nucl Cardiol
; 30(4): 1420-1426, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35581484
2.
Impact of forced diuresis with furosemide and hydration on the halo artefact and intensity of tracer accumulation in the urinary bladder and kidneys on [68Ga]Ga-PSMA-11-PET/CT in the evaluation of prostate cancer patients.
Eur J Nucl Med Mol Imaging
; 48(1): 123-133, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32385647
3.
Organ-sparing surgery of penile cancer: higher rate of local recurrence yet no impact on overall survival.
World J Urol
; 38(2): 417-424, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31062123
4.
Current status of functional imaging in neuroblastoma, pheochromocytoma, and paraganglioma disease.
Wien Med Wochenschr
; 169(1-2): 25-32, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30182289
5.
Comparison of [68Ga]Ga-PSMA-11 PET/CT with [18F]NaF PET/CT in the evaluation of bone metastases in metastatic prostate cancer patients prior to radionuclide therapy.
Eur J Nucl Med Mol Imaging
; 45(11): 1873-1883, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29766246
6.
Early dynamic imaging in 68Ga- PSMA-11 PET/CT allows discrimination of urinary bladder activity and prostate cancer lesions.
Eur J Nucl Med Mol Imaging
; 44(5): 765-775, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27900519
7.
68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour.
Eur J Nucl Med Mol Imaging
; 44(6): 941-949, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28138747
8.
Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence.
Eur J Nucl Med Mol Imaging
; 44(10): 1647-1655, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28589253
9.
Current knowledge on the sensitivity of the (68)Ga-somatostatin receptor positron emission tomography and the SUVmax reference range for management of pancreatic neuroendocrine tumours.
Eur J Nucl Med Mol Imaging
; 43(11): 2072-83, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27174220
10.
Visualization of malignant infiltration of the thoracic duct on 68Ga PSMA-11 PET/CT in a prostate cancer patient with biochemical recurrence.
Eur J Nucl Med Mol Imaging
; 47(8): 2042-2043, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31838582
11.
(68)Ga-DOTA (0)-Tyr (3)-octreotide positron emission tomography in nasopharyngeal carcinoma.
Eur J Nucl Med Mol Imaging
; 42(1): 20-4, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25227762
12.
Nuclear imaging of neuroendocrine tumors with unknown primary: why, when and how?
Eur J Nucl Med Mol Imaging
; 42(7): 1144-55, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25771906
13.
(68)Ga-DOTATOC PET/CT provides accurate tumour extent in patients with extraadrenal paraganglioma compared to (123)I-MIBG SPECT/CT.
Eur J Nucl Med Mol Imaging
; 42(1): 33-41, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25134670
14.
(68)Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
Eur J Nucl Med Mol Imaging
; 42(8): 1284-94, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25975367
15.
Unrecognized paraganglioma of the urinary bladder as a cause for basilar-type migraine.
Urol Int
; 92(4): 482-7, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-23735539
16.
Correlation of 99mTc-DPD bone scintigraphy with histological amyloid load in patients with ATTR cardiac amyloidosis.
Amyloid
; 31(1): 22-31, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37530216
17.
Somatostatin receptor PET in neuroendocrine tumours: 68Ga-DOTA0,Tyr3-octreotide versus 68Ga-DOTA0-lanreotide.
Eur J Nucl Med Mol Imaging
; 40(3): 364-72, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23151915
18.
A retrospective comparison between 68Ga-DOTA-TOC PET/CT and 18F-DOPA PET/CT in patients with extra-adrenal paraganglioma.
Eur J Nucl Med Mol Imaging
; 40(12): 1800-8, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24072345
19.
Screening for osteoporosis in people with MS: A new risk score.
Mult Scler Relat Disord
; 74: 104726, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37098303
20.
Nephrotoxicity and hematotoxicity one year after four cycles of peptide receptor radionuclide therapy (PRRT) and its impact on future treatment planning - A retrospective analysis.
Rev Esp Med Nucl Imagen Mol (Engl Ed)
; 41(3): 138-145, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35577489